For the first time, we further identified 5 EALMRGs (ABCB1, CAP1, EGFR, PPARG, and SNCA) that might become prognostic biomarkers of PAAD, of which EGFR exhibited better prognostic efficiency than other genes. The gene discussed is EGFR; the disease is pancreatic adenocarcinoma.